Passa al contenuto
Merck
Tutte le immagini(3)

Key Documents

Altri documenti

STS0212

Sigma-Aldrich

ECO BRIJ® L4

greener alternative

average Mn ~362

Sinonimo/i:

Brij® L4, Polyethylene glycol dodecyl ether, Polyoxyethylene (4) lauryl ether

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(3)

About This Item

Formula condensata:
(C20H42O5)n
Numero CAS:
9002-92-0
Numero MDL:
MFCD00043063

Descrizione

non-ionic

Livello qualitativo

200

Forma fisica

semisolid (may be liquid)

PM

average Mn ~362

Caratteristiche più verdi

Use of Renewable Feedstocks
Design for Degradation
Learn more about the Principles of Green Chemistry.

Impurezze

≤1.0% water

Indice di rifrazione

n20/D 1.451 (lit.)

Numero di acido

≤2.0 mg KOH/g

Indice di ossidrile

144‑165 mg KOH/g

Densità

0.95 g/mL at 25 °C (lit.)

HLB

9.7

Categoria alternativa più verde

Aligned,

Stringa SMILE

CCCCCCCCCCCCOCCOCCOCCOCCO

InChI

1S/C20H42O5/c1-2-3-4-5-6-7-8-9-10-11-13-22-15-17-24-19-20-25-18-16-23-14-12-21/h21H,2-20H2,1H3
WPMWEFXCIYCJSA-UHFFFAOYSA-N

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Categorie correlate

Descrizione generale

ECO Brij® L4, also known as polyethylene glycol lauryl ether, is a bio-based, nonionic surfactant manufactured from naturally occurring straight-chain lauryl alcohol. This detergent, derived from natural sources, provides various functional advantages, such as detergency, emulsification, and wetting, making it suitable for a range of applications in biochemical and biological research.
We are committed to bringing you Greener Alternative Products, which adhere to one or more of The 12 Principles of Green Chemistry. This product is a biobased surfactant and is aligned with the 7th principle of Green Chemistry "Use of Renewable Feedstocks" and the 10th principle "Design for Degradation".

Caratteristiche e vantaggi

  • 100 % Renewable
  • 100 % Bio-based
  • Certified to the USDA BioPreferred Program
  • Lower carbon footprint than petrochemical-based versions
  • High-purity chemical suitable for a wide variety of research applications

Proprietà fisiche

The ECO Brij series of ethoxylated fatty alcohols are non-ionic surfactants manufactured using renewable sources. ECO Brij L4 is a mixture of tetraethylene glycol alkyl ethers, primarily dodecyl (C12) ether. The alkyl ether profile of ECO Brij L4 may differ lot-to-lot due to natural variability in the lipid starting material (palm oil).

Altre note

For additional information on our range of Biochemicals, please complete this form.

Note legali

Brij is a registered trademark of Croda International PLC
ECO BRIJ is a registered trademark of Croda Inc.

Pittogrammi

Exclamation markEnvironment
GHS07,GHS09

Avvertenze

Warning

Indicazioni di pericolo

H302 - H315 - H319 - H411

Classi di pericolo

Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Skin Irrit. 2

Codice della classe di stoccaggio

10 - Combustible liquids

Classe di pericolosità dell'acqua (WGK)

WGK 2

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Ci dispiace, ma al momento non ci sono COA disponibili online per questo prodotto.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Jacomina W van den Esschert et al.
Annals of surgery, 255(2), 311-318 (2012-01-14)
To compare the safety and hypertrophy response after portal vein embolization (PVE) using 2 absorbable and 3 permanent embolization materials. Portal vein embolization is used to increase future remnant liver volume preoperatively. Application of temporary, absorbable embolization materials could be
Otte Brosjö et al.
Acta orthopaedica, 84(5), 502-505 (2013-11-01)
Recent data suggest that percutaneous sclerotherapy is a safe alternative to surgery for treatment of aneurysmal bone cysts (ABCs). We present our experience of this method. We retrospectively analyzed data from 38 consecutive patients treated with repeated injections of polidocanol.
Stefanie Reich-Schupke et al.
VASA. Zeitschrift fur Gefasskrankheiten, 42(1), 50-55 (2013-02-07)
According to the current guidelines for sclerotherapy hypercoagulability and thrombophilia with or without deep venous thrombosis are seen as relative contraindication for this treatment. But often such patients have an indication for a sclerotherapy. Recommendations for additional anticoagulation for sclerotherapy
A Erkin et al.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 44(6), 593-597 (2012-11-06)
Foam sclerosants are widely used in sclerotherapy and have been accepted as more effective than the liquid form; however, there is no consensus about the most applicable and effective concentration. The aim of this study was to investigate the histopathological
Takashi Yamaki et al.
Journal of vascular surgery, 56(6), 1649-1655 (2012-05-23)
This study assessed changes in the calf muscle deoxygenated hemoglobin (HHb) level during light-intensity exercise after ultrasound-guided foam sclerotherapy (UGFS) for superficial venous insufficiency. UGFS with 1% or 3% polidocanol foam (POL-F) was used to treat unilateral great saphenous vein
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.